Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial
Titel:
Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trial
Auteur:
Xu, B. Sun, T. Zhang, Q. Zhang, P. Yuan, Z. Jiang, Z. Wang, X. Cui, S. Teng, Y. Hu, X.-C. Yang, J. Pan, H. Tong, Z. Li, H. Yao, Q. Wang, Y. Yin, Y. Sun, P. Zheng, H. Cheng, J. Lu, J. Zhang, B. Geng, C. Liu, J. Shen, K. Yu, S. Li, H. Tang, L. Qiu, R.